New Frontiers in Computing Conference
Credit: Advantech Digital Healthcare
NFIC
2012
Emerging
Medical
Computing:
Health Care Up
Close &
Personalized
14th Annual NFIC Conference
Braun Auditorium, Stanford University, Saturday, June 16, 2012
1
Table of Contents
Schedule……………………………………………………………………………………………………..…………………….2
2
About NFIC…………………………………………………………………………….……….…………………………...……3
3
Letter from the Co-Chairs………………………………………………………………………………………………....4
4
Speaker Biographies
Michael P. Snyder, Ph.D. ……………………………………………………………….……………….…………66
Nicholas Eriksson, Ph.D. ……………………………………… ……………………………………………………8
8
Yan Chow, MD, MBA………………………………………………………………………………………….……….9
9
Parag Mallick, Ph.D. ……………………………………………………………………………………………….…..10
10
Tanveer Syeda-Mahmood, Ph.D. .………………………………………………………………………….……11
11
Charles C. Koo, Ph.D. ………………………………………………………………………………………………….12
12
Gregory V. Simpson, Ph.D. …………………………………………………………………………….………..….13
13
Douglas Trauner……………………………………………………………………………………………….…..…….14
14
15
Acknowledgements…………………………………………………………………………………………………….…......15
Conference Schedule
8:30 AM - 9:15 AM
Registration & Networking
9:15 AM - 9:30 AM
"Introductory Remarks", Mineo Yamakawa, Ph.D.
9:30 AM - 10:30 AM
Keynote: "Adventures in Personal Genomics and Whole Omics Profiling",
Michael P. Snyder, Ph.D.
10:30 AM - 10:50 AM
Coffee Break
10:50 AM - 11:30 AM
"Participant Driven Online Genetic Research at 23andMe",
Nicholas Eriksson, Ph.D.
11:30 AM - 12:30 PM
Lunch
12:30 PM - 1:10 PM
"Data: A Grand Challenge for Future Medicine", Yan Chow, MD, MBA
1:10 PM - 1:50 PM
"Challenges in Multi-scale Data Interpretation for Cancer Diagnostics",
Parag Mallick, Ph.D.
1:50 PM - 2:30 PM
"AALIM", Tanveer Syeda-Mahmood, Ph.D.
2:30 PM - 3:10 PM
"Nocipoint Electrical Stimulation Therapy - Eliminates the Chronic Pain and
Restores Functions Permanently and Rapidly", Charles C. Koo, Ph.D.
3:10 PM - 3:20 PM
Coffee Break
3:20 PM - 4:00 PM
"Personalized Brain/Mind Assessment and Therapeutics",
Gregory V. Simpson, Ph.D.
4:00 PM - 4:40 PM
"A New Model for Improved Patient/Provider Care-Coordination",
Douglas Trauner
4:40 PM - 5:00 PM
Panel Discussion & Closing
2
About New Frontiers in Computing
Introduction
Keeping up to speed, especially in Silicon Valley, is crucial for today’s engineers and scientists. Possessing
adequate knowledge to make reasoned decisions regarding an emerging technology’s importance plays an
essential role in professional career success. The NFIC conference was organized to provide engineers and
scientists with an effective means to achieve that goal. For more information about NFIC, please visit our
website http://www.nfic-us.org.
Mission Statement and Vision
Co-organized initially by IEEE –Computer Society/Silicon Valley Chapter and NATEA in 1999, the New Frontiers in
Computing Conference started providing computer and engineering professionals with enough technical
information on a developing field to make informed decisions as to its role in their professional careers. It has
achieved this for the last 13 years by presenting an inexpensive one-day conference on emerging technologies
such as Cloud Computing, Nanotechnology, Multi Core Processors and RFID. The presenters are recognized
leaders and experts from both the research and the emerging application’s communities. Each presentation
provides the attendee with solid technical information regarding an important aspect of the emerging
technology.
Organizers
IEEE Computer Society, Santa Clara Valley Chapter: The IEEE Computer Society - Silicon Valley Chapter has over
2,500 members. The CS promotes an active exchange of ideas and technological innovation among its members.
It is the largest IEEE Computer Society Chapter in the world.
North America Taiwanese Engineering & Science Association (NATEA): The North America Taiwanese
Engineering & Science Association was founded on March 2, 1991 in Silicon Valley. Since then, NATEA has grown
into twelve Regional Chapters across North America with 2,200 members. Many members serve in leading-edge
technical and managerial positions and are founders of some of the most successful high-tech companies.
IEEE Stanford University: The student branch of IEEE at Stanford University promotes services and organizes
activities for the EE/CS graduate and undergraduate community at Stanford.
Past NFIC Conferences
13th NFIC (2011): Emerging Automotive Computing - Engineering in Overdrive, Stanford
12th NFIC (2010): Cloud Computing and the Web, San Jose State University
11th NFIC (2009): Handheld Devices, Stanford
10th NFIC (2008): Cloud Computing: The New Face of Computing, Stanford
9th NFIC (2007): Multi-Core Processors, Stanford
8th NFIC (2006): The World with RFID, The Biltmore Hotel, Santa Clara
7th NFIC (2005): Sensor Networks — The New Environment, Stanford
6th NFIC (2004): Semiconductors to Nanotechnology — The Coming Convergence, Stanford
5th NFIC (2003): Emerging Issues in Security, Mobility, and Privacy, Stanford
4th NFIC (2002): Bioinformatics, Stanford
3rd NFIC (2001): Nanotechnology, Stanford
2nd NFIC (2000): Internet Protocol Telephony, Stanford
1st NFIC (1999): Systems on a Chip, Stanford
3
Letter from the Co-Chairs
Dr. Mineo Yamakawa
Roshni Cooper
Tiffany Tsao
Message from the Co-Chairs
As the conference co-chairs, we are pleased to welcome you all to the 14th Annual New Frontiers in
Computing Conference, "Emerging Medical Computing: Healthcare Up-Close and Personalized". We
hope you enjoy our wonderful lineup of distinctive speakers and networking opportunities during the
conference.
As computing advances faster than exponential rates, medical and healthcare professionals and
practitioners are now taking advantage of more powerful computer hardware and software structures
with large-scale global connectivity than ever before to handle exploding “big data” and evolving
complex algorithms with “low latency”. The speakers we have today cover a broad spectrum of topics
with visions for the future from cutting-edge computing applications to their practical
implementations. The topics start with genomics for personalized medicine in the morning sessions
and go on in the afternoon to focus on the challenges of a large-scale medical data and analytics as
well as personalized diagnostics and treatments “now”, and conclude with emerging models of
improved and cost-effective care-provider/patient communications through personalized medicine
and healthcare.
It is always our goal to make this conference as valuable as possible for the attendees, and we are
thrilled to present NFIC2012 as one of our most significant years yet. We hope you feel likewise.
Warmest and best regards,
Mineo Yamakawa, Ph.D.
Conference Co-Chair & Program
Chair, IEEE Santa Clara Valley Computer Society
Roshni Cooper
Conference Co-Chair
Stanford IEEE Student
Chapter
Tiffany Tsao
Conference Co-Chair
NATEA Silicon Valley
Dr. Mineo Yamakawa is a technical consultant with a "hybrid" background of engineering/medicine,
academic/industry, research/management, and US/Japan. Currently he is working on the project at
Hewlett-Packard Labs for business and technical strategies and DARPA project development. His
technical expertise specializes in data analysis and algorithm development for biological and nonbiological signals. His management expertise specializes in people management, business and IP
strategies, and technical collaboration liaison between "hybrid" cross-domains. Dr. Yamakawa received
his Ph.D. in Physiology & Biophysics from The University of Oklahoma Health Sciences Center and
Bachelor of Engineering in Applied Physics from Waseda University in Japan.
4
Roshni Cooper is a Ph.D. candidate in Electrical Engineering at Stanford University. Her research
focuses on image processing applied to the biological imaging of neurons. Prior to attending Stanford,
Roshni was a hardware engineer at Cisco Systems, where she developed video processing algorithms
for Telepresence, Cisco's HD video conferencing system. Roshni holds Bachelor of Science and Master
of Engineering degrees from MIT. Her thesis topic was the hardware and software development of
handheld biomedical devices for neuromuscular health assessment.
Tiffany Tsao is a Product Design Engineer at NETGEAR, Inc and focuses on the Retail Business Unit's
wireless router and adapter product lines. She is an active member in the community and currently
serves as Secretary General for the North America Taiwanese Engineering & Science Association, a
Board of Directors for the Silicon Valley Engineering Council, and Secretary for the Society of Women
Engineers Santa Clara Valley Section. Tiffany graduated from UCLA in 2010 with a B.S. in Materials
Science and was awarded the Russell R. O'Neill Distinguished Service Award.
5
Keynote Speaker
Michael P. Snyder, Ph.D.
Professor and Chair of Genetics and Director of
Stanford Center for Genomics and Personalized
Medicine, Stanford University
"Adventures in Personal Genomics
and Whole Omics Profiling"
Biography
Michael Snyder is the Stanford Ascherman Professor and Chair of Genetics and the Director of the
Center of Genomics and Personalized Medicine. Dr. Snyder received his Ph.D. training at the California
Institute of Technology and carried out postdoctoral training at Stanford University. He is a leader in
the field of functional genomics and proteomics. His laboratory study was the first to perform a largescale functional genomics project in any organism, and has launched many technologies in genomics
and proteomics. These including the development of proteome chips, high resolution tiling arrays for
the entire human genome, methods for global mapping of transcription factor binding sites (ChIP-chip
now replaced by ChIP-seq), paired end sequencing for mapping of structural variation in eukaryotes,
and RNA-Seq. These technologies have been used for characterizing genomes, proteomes and
regulatory networks. Seminal findings from the Snyder laboratory include the discovery that much
more of the human genome is transcribed and contains regulatory information than was previously
appreciated, and a high diversity of transcription factor binding occurs between and within species. He
is a cofounder of several biotechnology companies, including Protometrix (now part of Life
Technologies), Affomix (now part of Illumina), Excelix, and Personalis, and he presently serves on the
board of a number of companies.
Abstract
Personalized medicine is expected to benefit from the combination of genomic information with the
global monitoring of molecular components and physiological states. To ascertain whether this can be
achieved, we determined the whole genome sequence of an individual at high accuracy and performed
an integrated Personal Omics Profiling (iPOP) analysis, combining genomic, transcriptomic, proteomic,
metabolomic, and autoantibodyomic information, over a 21-month period that included healthy and
two virally infected states. Our iPOP analysis of blood components revealed extensive, dynamic and
broad changes in diverse molecular components and biological pathways across healthy and disease
conditions. Importantly, genomic information was also used to estimate medical risks, including Type 2
Diabetes, whose onset was observed during the course of our study. Our study demonstrates that
longitudinal personal omics profiling can relate genomic information to global functional omics activity
for physiological and medical interpretation of healthy and disease states.
6
The following people contributed to this work:
Rui Chen1*, George I. Mias1*, Jennifer Li-Pook-Than1*, Hugo Y. K. Lam1*, Lihua Jiang1*, Rong Chen2,
Elana Miriami1, Konrad J. Karczewski1, Manoj Hariharan1, Frederick E. Dewey3, Lukas Habegger4,5,
Michael J. Clark1, Suganthi Balasubramanian4,5, Yong Cheng1, Maeve O’Huallachain1, Joel T. Dudley2,
Sara Hillenmeyer1, Rajini Haraksingh1, Donald Sharon1, Ghia Euskirchen1, Phil Lacroute1, Keith
Bettinger1, Hogune Im1, Alan P. Boyle1, Maya Kasowski1, Fabian Grubert1, Scott Seki2, Marco Garcia2,
Michelle Whirl-Carrillo1, Mercedes Gallardo6,7, Maria A. Blasco6, Peter L. Greenberg8, Phyllis Snyder1,
Teri E. Klein1, Russ B. Altman1,9 Atul Butte2, Euan A. Ashley3, Kari C. Nadeau2, Mark Gerstein4,5,10, Hua
Tang1 and Michael Snyder1§
1.
2.
3.
Department of Genetics, Stanford University School of Medicine, Stanford, CA 94305, USA.
Department of Pediatrics, Stanford University, Stanford, CA 94305, USA.
Center for Inherited Cardiovascular Disease, Division of Cardiovascular Medicine, Stanford
University, Stanford, CA 94305, USA.
4. Program in Computational Biology and Bioinformatics, Yale University, New Haven, Connecticut
06520, USA;
5. Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, Connecticut
06520, USA;
6. Telomeres and Telomerase Group, Molecular Oncology Program, Spanish National Cancer Centre
(CNIO), Melchor Fernández Almagro 3, Madrid, E-28029, Spain.
7. Life Length, Agustín de Betancourt 21, Madrid, E-28003, Spain.
8. Division of Hematology, Department of Medicine, Stanford University, Stanford, CA 94305, USA.
9. Department of Bioengineering, Stanford University, Stanford, CA 94305, USA.
10. Department of Computer Science, Yale University, New Haven, CT 06520, USA
§ Correspondence should be addressed to: mpsnyder@stanford.edu.
* These authors contributed equally to this work
7
Speaker
Nicholas Eriksson, Ph.D.
Principal Scientist, 23andMe
“Participant Driven Online
Genetic Research at 23andMe”
How direct consumer genetic testing is leading
to progress in the study of the genetics of
human traits and diseases.
Biography
Dr. Eriksson is a principal scientist at 23andMe. He leads the analysis of 23andMe's genome-wide
association studies, which allow the public to participate in the forefront of genetic research and reap
the benefits of the resulting advances in the field. Dr. Eriksson received a Ph.D. in Mathematics from
UC Berkeley in 2005. He was an NSF postdoctoral fellow at Stanford University and a Visiting Assistant
Professor at the University of Chicago before joining 23andMe in 2008. Outside of statistical genetics,
his research interests include evolutionary and computational biology, discrete mathematics, and
statistics.
Abstract
With the costs of genotyping and sequencing dropping rapidly, bringing together individuals to collect
phenotypes has become a proportionally greater hurdle in genetic research. As the flurry of genetic
progress in the last decade has created an excitement about genetics in the public, 23andMe has
brought this excitement to consumers, allowing them to learn about their genetics and to participate in
new genetic research using web-based surveys. With over 100,000 genotyped customers who have
enrolled in our IRB-approved research program, we have been able to study over 1000 different
diseases, traits, and conditions. I will present a series of novel findings from this unique research
platform, including genetic associations for Parkinson's disease, hypothyroidism, allergies, and a wide
variety of morphological traits.
8
Speaker
Yan Chow, MD, MBA
Director, Innovation and Advanced
Technology, Kaiser Permanente
Information Technology
"Data: A Grand Challenge for
Future Medicine"
Health care is in the early stages of a
tremendous explosion in data that must be
managed and understood.
Biography
Dr. Chow is Director of Kaiser Permanente (KP) Information Technology’s Innovation & Advanced
Technology Group, which investigates new and emerging health information technologies that will
impact health care in the next 2 to 5 years. Dr. Chow has been involved with information systems at KP
for several decades. He has also founded startups in the Internet, storage, and database spaces,
receiving 3 U.S. patents in 2004 for ultrafast network storage. Dr. Chow earned his AB from Harvard,
MD from UC San Diego, and MBA (valedictorian) from UC Berkeley’s Haas School of Business in 2005.
Kaiser Permanente is the largest private integrated care delivery system in the U.S., with nearly 9M
members, 167,000 employees, and 15,000 physicians. KP has won many awards for its technology
leadership.
Abstract
One of the grand challenges of medicine in the coming decades will be the management and
interpretation of big data. The explosion of data from numerous sources, such as the biomedical
research literature, electronic medical records, lab and imaging systems, pharmacy transactions,
numerous IT infrastructure systems, on-site and remote patient monitoring, geospatial data,
biosurveillance, email and social media, and sentiment analysis, threatens to overwhelm our ability to
keep up. This session will discuss big data issues and related healthcare use cases at a level appropriate
to the emerging status of the big data industry.
9
Speaker
Parag Mallick, Ph.D.
Assistant Professor, Canary Center for
Cancer Early Detection, Stanford
University
“Challenges in Multi-scale
Data Interpretation for
Cancer Diagnostics”
Computation, Simulation and Cancer
Diagnosis
Biography
Dr. Mallick received his BS in computer science and biochemistry from Washington University in St.
Louis and his PhD from the University of California, Los Angeles, in chemistry and biochemistry. He
next moved to the state of Washington as a postdoctoral fellow at the Institute for Systems Biology in
Seattle, where he researched clinical and quantitative systems biology. Prior to coming to Stanford, Dr.
Mallick was as an assistant professor in the Departments of Medicine and Biomedical Engineering at
the University of Southern California (USC) and the director of clinical proteomics at the Center for
Applied Molecular Medicine (CAMM). At Stanford, his research focus is on multiscale approaches for
the discovery of serologic and imaging biomarkers for cancer early detection in lung, pancreatic,
prostate cancers, and lymphoma.
Abstract
We hypothesize that accurate methods for simulating cancer behavior may lead to dramatic
improvements in cancer management as these simulations could be used to predict and characterize
response and outcome, which in turn could ‘handicap the odds’ of a therapy succeeding.
Consequently, our principle focus and vision is the creation of a virtual cancer able to accurately
predict the steady state growth and response to therapy of a cancer in a human host. In addition to
helping us ask and answer fundamental questions about cancer mechanism, complexity and evolution,
this virtual cancer will enable a new paradigm in treatment. Through our virtual cancer, we anticipate it
will become possible to take a small number of measurements from a patient, at a variety of scales
from genetic to organismic, input those measurements as calibrants to our virtual cancer and then
simulate the growth and response to therapy of the patient. The development of such models is
challenged by the confounding observations that some molecular level changes are insignificant from
the perspective of the tumor while others can produce dramatic, tumor-scale (e.g., aggressiveness) and
organism scale (e.g., positive outcome) affects. Here we will describe the overall objectives of our
center and highlight some initial multi-scale findings.
10
Speaker
Tanveer Syeda-Mahmood Ph.D.
Fellow, IEEE; Master Inventor, Member,
IBM Academy of Technology; Research
Manager, Multi-modal Mining for
Healthcare, IBM Almaden Research
Center
"AALIM" - A Multimodal
clinical informatics platform
for decision support
Biography
Tanveer Syeda-Mahmood, Ph.D.
Fellow, IEEE; Master Inventor, Member, IBM Academy of Technology; Research Manager, Multi-modal
Mining for Healthcare, IBM Almaden Research Center
Abstract
Diagnostic decision support is still being done in physician's offices today based on evidence from a
single patient and their own a-priori knowledge. AALIM is a clinical informatics system that offers
statistically-supported conclusions gleaned from pre-diagnosed databases of electronic health records
thus reflecting consensus opinions of other clinicians who looked at similar patients. The key to
statistical decision making is finding similar patients based on a disease-specific analysis of their clinical
data. AALIM demonstrates this in the domain of cardiology leveraging the content in
electrocardiograms (EKG), echocardiograms, coronary angiograms, in addition to textual reports, lab
results and structured clinical data. Besides presenting holistic information about patients for decision
support, AALIM can also be used as a platform for comparative effectiveness research based on
retrospective population data correlating diagnosis, treatments and outcome. The AALIM system is
moving from research settings to pilot clinical use in hospitals around the world.
11
Speaker
Charles C. Koo, Ph.D.
Managing Director, Pain Cure Center & Visiting
Scholar, Electrical Engineering, Stanford
University
"Nocipoint Electrical Stimulation
Therapy - Eliminates the Chronic
Pain and Restores Functions
Permanently and Rapidly"
Biography
Personalized cure of the chronic pain
Dr. Koo is Managing Director of Pain Cure Center and Visiting Scholar at Stanford University. He
founded and led five venture-backed high-tech companies, two of which were acquired by public
companies. One of the companies he started, Aprima, has been a top EHR company since 1999. He
was named in "Movers and Shakers" by Frost & Sullivan in 2004. Meanwhile, Dr. Koo has personally
helped over 1500 people free from their chronic pain during those years with his new therapy. He is
currently invited by EE of Stanford University as a Visiting Scholar to conduct research on the pain and
pain relief devices. Dr. Koo received two master level degrees and his PhD at Stanford.
Abstract
Over 112M Americans suffer from chronic pain, according to CDC report in 2011. Current modalities,
including the analgesic medication, the physical therapy, the steroid injection and the surgery, only
offer limited relief. Nocipoint Therapy is an unique electrical stimulation on precise locations with
specific duration and intensity of the stimulation. The therapy removes the pain and persistently
restores the muscle or tendon function within a short period of time. An observational study of
Nocipoint Therapy demonstrated a 93% success rate in eliminating the chronic pain, such as frozen
shoulder pain, within 2-3 sessions of the therapy. A controlled clinical study approved by Independent
Review Board (IRB) is underway comparing Nocipoint Therapy and the physical therapy (PT), the
standard of care. The preliminary result to date shows an order-of-magnitude improvement of
Nocipoint Therapy over PT, both in the efficacy and the time required. Nocipoint Therapy works on a
wide range of conditions with the same rapid and permanent outcomes: neck pain, shoulder pain, back
pain, tendonitis and sciatica. Though with smaller number of cases, it also works on other pains such
as migraine, menstrual pain, temporomandibular joint (TMJ) disorder, etc. The wide range of
applicability and the high success rate imply a deterministic neuro-immunal signaling pathway,
triggered by the electrical signal of the therapy.
12
Speaker
Gregory V. Simpson, Ph.D.
Founder and CSO, Think Now, Inc.; Senior
Scientist, Brain Plasticity Institute
"Personalized Brain/Mind
Assessment and Therapeutics"
Brain wave and behavioral measures on smart
phones will transform phenotyping, mental
therapeutics and social valuations of cognitive
differences.
Biography
Dr. Simpson is a cognitive neuroscientist involved in leading-edge brain research, the development of
novel neuroplasticity-based tools for training the brain/mind and creation of companies to translate
these inventions into real-world products/benefits. Formerly the Director of the Dynamic
Neuroimaging Laboratory at UCSF, he is currently a Senior Scientist at the Brain Plasticity Institute and
the founder and CSO of Think Now, Inc., a company producing neuroplasticity-based cognitive training
software based upon inventions related to the control of attention. His company, Think Now, is also
developing personalized software and brain recording tools for neuropsychological testing, diagnostics
and monitoring treatment efficacy for psychiatric and neurological disorders. He is an investigator and
consultant on studies of the neural bases of attentional control, its relationship to emotional balance,
and software-based training of attentional control with colleagues at UCLA and UCSF.
Abstract
My talk will focus on brain/mind assessment and therapeutics using mobile technologies, including
electroencephalography (EEG), and how these technologies are driving a much-needed revolution in
phenotyping mental function leading to the creation of more effective products for improving mental
well-being and interventions for disorders. Mobile technologies can be disruptive because they have
the ability to: (1) be specific to the individual; (2) adapt to the myriad real-world contexts that greatly
influence brain function and behavior; and (3) dynamically adapt with the constantly changing brain
and mind at both the individual and social levels. The plasticity of our brain creates a striking dynamic.
Our brains constantly adapt to what we experience, changing how we behave, consequently through
our altered actions we change the environment (physically and socially), and that altered environment
influences what our brains experience and adapt to. This is a very powerful causal loop that can be
directly altered with in situ mobile technologies. Great advances are being made with mobile
applications and wireless electroencephalography (EEG), and I will discuss the challenges for the IEEE
and computing community.
This new field involves extensive data-mining, development of new cognitive tests and cognitive
training methods, and new realms of neuroscience research, all of which are integrated and
13
dynamically evolving as each informs the other.
14
Speaker
Douglas Trauner
CEO and Founder, Health Analytic Services,
Inc. / TheCarrot.com
"A New Model for Improved
Patient/Provider CareCoordination"
How the convergence of health education, selfmanagement tools and patient management
are redefining clinical relationships.
Biography
Mr. Trauner founded Health Analytic Services, Inc. in 2007 and launched the care-coordination
platform of TheCarrot.com in 2008 to enable healthcare providers to improve the management of
outpatient care. Mr. Trauner is a frequent speaker on the subject of patient engagement and privacy
and previously co-founded PM Squared, Inc., a health care information company that was acquired by
United Healthcare. Mr. Trauner has an engineering degree from the University of California at San
Diego. TheCarrot.com is an award-winning, mobile and online service that helps healthcare providers
coordinate discharge planning, chronic care services and patient self-management. Using
TheCarrot.com, patients can follow prescribed protocols to track and manage their health progress for
thousands of health measures. Users maintain strict privacy control for the sharing their health
information with care organizations, family members or individuals in online communities.
Abstract
The proliferation of smart phones, mobile health applications and electronic medical devices has added
a new dimension to the provider-patient relationship, namely care-coordination outside the clinical
setting. To date, care-coordination involving patient self-management activities has had limited
provider adoption and has not been well supported by inpatient and ambulatory electronic medical
record systems (EMRs). Remote care-coordination enables the collection of a wide range of data to
support patient follow-up after hospital discharge, for managing chronic conditions, handling lifestyle
interventions, and recovery from traumatic events. For example, following a coronary stent
procedure, a patient may be asked to report pain levels and transmit photos of the wound to show
bruising, bleeding or discharge; a newly diagnosed diabetic patient may go to a community
organization for nutrition counseling and glucose management, with detail on glucose levels, diet, and
exercise being shared with local diabetes educators and treating physicians. Providers are able to
effectively manage a population of patients in real-time, with the ability to generate alerts and
prioritize cases for follow-up. A body of evidence continues to grow that remote care-coordination
reduces the cost of care along with improving patient outcomes and satisfaction. With today EMRs
focusing on inpatient and ambulatory workflow, a new class of solutions are emerging to support
15
patient care coordination outside of the clinical setting.
Thank you for attending the 2012 New Frontiers in
Computing Conference
NFIC is a Collaboration Between
Mineo Yamakawa, Ph.D. (Co-Chair)
Patrick Fasang, Ph.D. (Editor)
Steven Ganz, Ph.D.
Michael Graebner, Ph.D.
Hans Spanjaart
Fei Wang, Ph.D.
Dan Yamakawa
Tiffany Tsao (Co-Chair)
Carson Chen, Ph.D.
Frank Guan
T.Y. Lin, Ph.D.
Eaden Saw, Ph.D.
Steve Wu, Ph.D.
John Pang Yu, Ph.D.
Roshni Cooper (Co-Chair)
NFIC Advisory Board Members
T.Y. Lin, Ph.D., Michael Graebner, Ph.D.
John Pang Yu, Ph.D.
16
Preferred infrastructure in Life Science: Information Retrieval
Our full-text indexing algorithm can handle a large amount of nucleotide and amino-acid
sequences. It supports approximate string marching and short sequence matching efficiently. The
algorithm is tuned for SOLID STATE DRIVERS and therefore you can handle a lot of sequence data
without memory-monster machine.
We also provide:
Recommendation Engines / Natural Language Processing / Distributed Computing
Succinct Data Structures / Compression Algorithms
Preferred Infrastructure, Inc.
Web: http://preferred.jp/ Mail: info@preferred.jp
17